Indoco Remedies Ltd (INDOCO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 601817, "name": "Indoco Remedies", "stock_name": "Indoco Remedies", "full_name": "Indoco Remedies Ltd", "name_url": "stocks-analysis/indoco-remedies", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "205.45", "chg": -0.1, "chgp": "-0.05%", "dir": -1, "prev_price": "205.55", "mcapval": "1,906.00 Cr", "mcap": "Small Cap", "scripcode": 532612, "symbol": "INDOCO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE873D01024", "curr_date": "Jun 10, 03:30 PM", "curr_time": "03:46 AM", "last_traded_at": "Jun 10, 03:30 PM IST", "bse_nse_vol": "2.97 lacs", "exc_status": "Active", "traded_date": "Jun 10, 2026", "traded_date_str": "2026 06 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indoco-remedies-601817-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Indoco Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4043164", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndocoRemediesL_valuationdot_4043164.png", "date": "2026-06-10 08:00:56", "description": "Indoco Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing sector headwinds. This repositioning comes amid a backdrop of subdued returns relative to the broader market and a deteriorating profitability profile, raising important considerations for investors evaluating its price attractiveness against peers and historical benchmarks." }, { "title": "Indoco Remedies Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-4030535", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndocoRemediesL_mojoScore_4030535.png", "date": "2026-06-02 10:10:35", "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 June 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Indoco Remedies Ltd Opens 6.01% Higher in Sharp Gap Up, But Can the Technicals Support It?", "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-opens-strong-with-significant-gap-up-on-29-may-2026-4019572", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_gapup_4019572.png", "date": "2026-05-29 09:40:13", "description": "" }, { "title": "Indoco Remedies Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-4004869", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_mojoScore_4004869.png", "date": "2026-05-22 10:10:40", "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Indoco Remedies Declines 1.38%: Downgrade and Mixed Technicals Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-declines-138-downgrade-and-mixed-technicals-shape-the-week-3994724", "imagepath": "", "date": "2026-05-16 17:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Downgrade to Strong Sell amid deteriorating quality and sharp 3.86% price drop</p>\n <p><strong>12 May:</strong> Technical momentum shifts to mildly bearish with 1.30% decline</p>\n <p><strong>13 May:</strong> Short-term rebound with 4.36% gain amid mixed technical signals</p>\n <p><strong>15 May:</strong> Week closes at Rs.225.05, down 0.49% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.228.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\"..." }, { "title": "Indoco Remedies Ltd Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-technical-momentum-shifts-amid-bearish-signals-3986466", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_technicaldot_3986466.png", "date": "2026-05-12 08:04:20", "description": "Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. The stock’s recent downgrade to a Strong Sell rating by MarketsMOJO underscores growing concerns amid a mildly bearish trend and a 3.86% decline in daily price." }, { "title": "Indoco Remedies Downgraded to Strong Sell Amid Weak Fundamentals and Mixed Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-downgraded-to-strong-sell-amid-weak-fundamentals-and-mixed-technicals-3984746", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_mojoScore_3984746.png", "date": "2026-05-11 08:02:29", "description": "Indoco Remedies Ltd has been downgraded from a Sell to a Strong Sell rating as of 8 May 2026, reflecting deteriorating fundamentals and a cautious technical outlook. The pharmaceutical company’s quality grade has slipped to below average, valuation has improved to attractive, financial trends remain weak, and technical indicators have shifted to a sideways stance. This comprehensive reassessment highlights the challenges facing Indoco Remedies amid a tough industry backdrop and persistent operational headwinds." }, { "title": "Indoco Remedies Ltd Faces Technical Momentum Shift Amid Bearish Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-faces-technical-momentum-shift-amid-bearish-sentiment-3984634", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_technicaldot_3984634.png", "date": "2026-05-11 08:01:43", "description": "Indoco Remedies Ltd has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade to a Strong Sell rating, the stock’s technical indicators reveal a sideways trend with mixed momentum, underscoring the challenges faced by this small-cap pharmaceutical player in a volatile market environment." }, { "title": "Indoco Remedies Ltd Downgraded to Strong Sell as Quality Parameters Deteriorate", "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-downgraded-to-strong-sell-as-quality-parameters-deteriorate-3984433", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_qualitydot_3984433.png", "date": "2026-05-11 08:00:06", "description": "Indoco Remedies Ltd has seen its quality grade downgraded from average to below average, reflecting a notable deterioration in key business fundamentals. The pharmaceutical company’s financial metrics, including return on equity (ROE), return on capital employed (ROCE), and debt levels, reveal a challenging operational environment that has weighed on investor sentiment and market performance." } ], "total": 574, "sid": "601817", "stock_news_url": "https://www.marketsmojo.com/news/indoco-remedies-601817" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "28-May-2026", "details": "Indocos formulation plant at Baddi (Plant III) receives EU GMP Certification", "source": "BSE" }, { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "22-May-2026", "details": "Enclosed the Annual Secretarial Compliance Report dated 13-05-2026 for the Financial Year 2025-2026 issued by our Secretarial auditor CS Ajit Sathe Proprietor of M/s. A.Y.Sathe & Co Company Secretaries.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements", "datetime": "18-May-2026", "details": "Intimation regarding completion of transfer of Ophthalmic Division of the Company to Sunways (India) Private Limited", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Indoco Remedies Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Sep 25", "dt": "2025-09-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Indoco Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 17 May 12", "dt": "2012-05-17", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Indoco Remedies Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 17 May 12", "dt": "2012-05-17", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

11 May: Downgrade to Strong Sell amid deteriorating quality and sharp 3.86% price drop

12 May: Technical momentum shifts to mildly bearish with 1.30% decline

13 May: Short-term rebound with 4.36% gain amid mixed technical signals

15 May: Week closes at Rs.225.05, down 0.49% on the day

Week Open

Rs.228.20

Read full news article

Indoco Remedies Ltd Technical Momentum Shifts Amid Bearish Signals

2026-05-12 08:04:20

Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. The stock’s recent downgrade to a Strong Sell rating by MarketsMOJO underscores growing concerns amid a mildly bearish trend and a 3.86% decline in daily price.

Read full news article

Indoco Remedies Downgraded to Strong Sell Amid Weak Fundamentals and Mixed Technicals

2026-05-11 08:02:29

Indoco Remedies Ltd has been downgraded from a Sell to a Strong Sell rating as of 8 May 2026, reflecting deteriorating fundamentals and a cautious technical outlook. The pharmaceutical company’s quality grade has slipped to below average, valuation has improved to attractive, financial trends remain weak, and technical indicators have shifted to a sideways stance. This comprehensive reassessment highlights the challenges facing Indoco Remedies amid a tough industry backdrop and persistent operational headwinds.

Read full news article

Indoco Remedies Ltd Faces Technical Momentum Shift Amid Bearish Sentiment

2026-05-11 08:01:43

Indoco Remedies Ltd has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade to a Strong Sell rating, the stock’s technical indicators reveal a sideways trend with mixed momentum, underscoring the challenges faced by this small-cap pharmaceutical player in a volatile market environment.

Read full news article

Indoco Remedies Ltd Downgraded to Strong Sell as Quality Parameters Deteriorate

2026-05-11 08:00:06

Indoco Remedies Ltd has seen its quality grade downgraded from average to below average, reflecting a notable deterioration in key business fundamentals. The pharmaceutical company’s financial metrics, including return on equity (ROE), return on capital employed (ROCE), and debt levels, reveal a challenging operational environment that has weighed on investor sentiment and market performance.

Read full news article